BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 22722900)

  • 1. Particulate systems for targeting of macrophages: basic and therapeutic concepts.
    Moghimi SM; Parhamifar L; Ahmadvand D; Wibroe PP; Andresen TL; Farhangrazi ZS; Hunter AC
    J Innate Immun; 2012; 4(5-6):509-28. PubMed ID: 22722900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.
    Ahsan F; Rivas IP; Khan MA; Torres Suarez AI
    J Control Release; 2002 Feb; 79(1-3):29-40. PubMed ID: 11853916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome.
    Patel B; Gupta N; Ahsan F
    Eur J Pharm Biopharm; 2015 Jan; 89():163-74. PubMed ID: 25497488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of hexagonal polymeric micelles in macrophage phagocytosis.
    Tsai HC; Chang CH; Chiu YC; Lin SY; Lin CP; Hsiue GH
    Macromol Rapid Commun; 2011 Sep; 32(18):1442-6. PubMed ID: 21732463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2009 Mar; 98(3):812-43. PubMed ID: 18661544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
    Rajpoot K
    Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.
    Patel BK; Parikh RH; Patel N
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
    Colino CI; Lanao JM; Gutierrez-Millan C
    Front Immunol; 2020; 11():218. PubMed ID: 32194546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted drug delivery to macrophages.
    Jain NK; Mishra V; Mehra NK
    Expert Opin Drug Deliv; 2013 Mar; 10(3):353-67. PubMed ID: 23289618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.
    Lee WH; Loo CY; Traini D; Young PM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):1009-26. PubMed ID: 25912721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of nanotechnology-based Chinese herb drugs on biological activities.
    Huang S; Chang WH
    Curr Drug Metab; 2009 Oct; 10(8):905-13. PubMed ID: 20214585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage specific drug delivery in experimental leishmaniasis.
    Basu MK; Lala S
    Curr Mol Med; 2004 Sep; 4(6):681-9. PubMed ID: 15357216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers.
    Frenz T; Grabski E; Durán V; Hozsa C; Stępczyńska A; Furch M; Gieseler RK; Kalinke U
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):13-7. PubMed ID: 25701806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
    Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
    Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as nanovaccine delivery systems.
    Ghaffar KA; Giddam AK; Zaman M; Skwarczynski M; Toth I
    Curr Top Med Chem; 2014; 14(9):1194-208. PubMed ID: 24678703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
    Layek B; Singh J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK; Chung BH; Chung SJ
    Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.